Anti-PD1 monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-PD1 monoclonal antibody, covering 2025-07-02 to 2025-07-02. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection [Phase 1]